CTC (Chicago Trading Company)’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,983
Closed -$569K 302
2022
Q1
$808K Sell
10,983
-123,764
-92% -$11M ﹤0.01% 288
2021
Q4
$19.3M Sell
134,747
-44,006
-25% -$7.56M 0.01% 165
2021
Q3
$37.1M Buy
+178,753
New +$39.4M 0.02% 96

Other funds holding NVAX

CTC (Chicago Trading Company)'s NVAX Position: Q2 2022 in Review

CTC (Chicago Trading Company) sold out of Novavax (NVAX) in Q2 2022, closing a stake of 10,983 shares — an estimated $569K sold.

CTC (Chicago Trading Company) first reported a position in NVAX in Q3 2021 and held it in 3 quarters. The position peaked at $37.1M in Q3 2021. 326 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • CTC (Chicago Trading Company) reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 10,983 Novavax shares in Q2 2022, an estimated $569K.
  • CTC (Chicago Trading Company) first reported a position in Novavax in Q3 2021 and held it in 3 quarters.
  • CTC (Chicago Trading Company)'s Novavax position peaked at $37.1M in Q3 2021.
  • 326 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on CTC (Chicago Trading Company)'s 13F filing for Q2 2022, filed 7 Jul 2022.